Stephane Bancel

Stéphane Bancel is the President and CEO of Moderna Therapeutics. Bancel is a former CEO of the French diagnostics company bioMérieux and the former country sales manager at Eli Lilly in Belgium. BioMérieux is a French company with its U.S. headquarters in Cambridge, Massachusetts that specializes in “molecular diagnostics systems for health care, food safety, and industrial applications.” He worked at bioMérieux until 1998, and began at Eli Lilly in their UK manufacturing plant in 2000. As the CEO of bioMérieux, Bancel grew the company despite the worldwide economic recession.
Bancel has servered on the boards of other companies. Bancel joined the board of directors at Knome in 2010 after that company obtained an “exclusive licensing deal” with bioMérieux. The company launched in 2011 with $40M financing from Flagship Ventures to fund messenger RNA technology licensed from Harvard.
He joined Moderna Therapeutics, a small start-up.
Philanthropy
Stéphane Bancel is the Chairman and co-founder of the Take 5 Foundation with his wife, Brenda Bancel. The Take 5 Foundation is a Boston-based program that matches a “coach in their field of expertise with five underserved children over the course of a school year.”<ref name="TFF" />
Awards and recognition
In 2009, the World Economic Forum named Stéphane Bancel a “Young Global Leader.”<ref name="MTX" /> Also in 2009, the Forum des Relations Investisseurs-IR Intelligence recognized Bancel as the “Best CEO for Investor Relations in France.”<ref name="MTX" /> In 2011, Thomson Reuters EXTEL named him the #1 CEO in the biotechnology sector.<ref name="MTX" />

Main Menu

See Also

Main Menu